We are live on ! Find out more
KLRS

Kalaris Therapeutics

71 hedge funds and large institutions have $854M invested in Kalaris Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $19K | Put options by funds: $7K

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

51% more capital invested

Capital invested by funds: $566M → $854M (+$288M)

16% more funds holding

Funds holding: 6171 (+10)

0.17% more ownership

Funds ownership: 1.4%1.56% (+0.17%)

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
23
Reduced
14
Closed
12
Calls
$19K
Puts
$7K
Net Calls
+$12K
Net Calls Change
+$16K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$1.16M -$1.07M -1,397 -51%
DnB Asset Management
27
DnB Asset Management
Norway
$1.15M +$1M +1,306 New
Swiss National Bank
28
Swiss National Bank
Switzerland
$1.13M +$983K +1,278 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$1.04M
CS
30
Credit Suisse
Switzerland
$991K +$863K +1,122 New
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$973K +$846K +1,100 New
LCM
32
Laurion Capital Management
New York
$961K
SFI
33
Susquehanna Fundamental Investments
Pennsylvania
$898K -$167K -217 -18%
MS
34
Maven Securities
Jersey
$799K +$665K +865 New
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$765K +$128K +167 +24%
Deutsche Bank
36
Deutsche Bank
Germany
$717K +$220K +286 +54%
DekaBank Deutsche Girozentrale
37
DekaBank Deutsche Girozentrale
Germany
$703K +$635K +826 New
JG
38
Jefferies Group
New York
$630K +$549K +713 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$627K +$275K +357 +101%
EAM
40
Erste Asset Management
Austria
$607K +$549K +713 New
ProShare Advisors
41
ProShare Advisors
Maryland
$539K +$469K +610 New
GGHC
42
Gilder Gagnon Howe & Co
New York
$509K -$20K -26 -4%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$491K +$428K +556 New
CF
44
CNA Financial
Illinois
$434K +$18.5K +24 +5%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$423K +$44.6K +58 +14%
Wells Fargo
46
Wells Fargo
California
$402K -$127K -165 -27%
SAM
47
Sectoral Asset Management
Quebec, Canada
$375K -$8.97M -11,654 -96%
Marshall Wace
48
Marshall Wace
United Kingdom
$316K -$534K -694 -66%
JP Morgan Chase
49
JP Morgan Chase
New York
$310K +$46.2K +60 +21%
MIM
50
MetLife Investment Management
New Jersey
$308K

KLRS Hedge Fund Activity: Q4 2020 in Review

71 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kalaris Therapeutics (KLRS) for Q4 2020, worth a combined $854M — up 51% from $566M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KLRS positions and 12 closed out — a net gain of 10 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was American International Group, adding an estimated $30.1M. The largest seller was Sectoral Asset Management, cutting an estimated $8.97M.

  • 71 institutional investors held Kalaris Therapeutics (KLRS) as of Q4 2020, up from 61 in Q3 2020.
  • Funds reported $854M of Kalaris Therapeutics stock for Q4 2020, up 51% quarter-over-quarter.
  • 22 funds opened new Kalaris Therapeutics positions in Q4 2020 and 12 closed out, a net change of +10 holders.
  • The largest Kalaris Therapeutics buyer in Q4 2020 was American International Group, an estimated $30.1M added.
  • The largest Kalaris Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $8.97M sold.

Based on aggregated 13F filings for Q4 2020.